Cargando…
Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
The repurposing of colchicine for the treatment of COVID-19 was suggested based in its immunomodulatory, anti-inflammatory, and anti-viral properties. We performed a single-center propensity score matched cohort study, including all consecutive COVID-19 patients admitted to a community hospital betw...
Autores principales: | Brunetti, Luigi, Diawara, Oumou, Tsai, Andrew, Firestein, Bonnie L., Nahass, Ronald G., Poiani, George, Schlesinger, Naomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565543/ https://www.ncbi.nlm.nih.gov/pubmed/32937800 http://dx.doi.org/10.3390/jcm9092961 |
Ejemplares similares
-
Colchicine in COVID-19: an Old Drug, New Use
por: Schlesinger, Naomi, et al.
Publicado: (2020) -
Impact of tocilizumab administration on mortality in severe COVID-19
por: Tsai, Andrew, et al.
Publicado: (2020) -
Weathering the Storm
por: Cooper, Daniel H., et al.
Publicado: (2023) -
Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes
por: England, James T., et al.
Publicado: (2021) -
Weathering a Cytokine Storm: A Case of EBV-Induced Hemophagocytic Lymphohistiocytosis
por: Shaw, Tiffany Y., et al.
Publicado: (2016)